GlaxoSmithKline (GSK) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

GlaxoSmithKline (GSK) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 19, 2024 (10:40)

Sector: Healthcare

The share price of GlaxoSmithKline plc (GSK) now

Latest session on the 18th of July for
GlaxoSmithKline plc is negative
Trading Volume: 1592081
Open: 39.74 /  High: 39.83 /  Low: 39.29
What analysts predict: $46.58
52-week High/Low: $45.8 / $32.7

50/200 Day Moving Average: $41.82 / $39.63

This figure corresponds to the Average Price over the previous 50/200 days. For GlaxoSmithKline stocks, the 50-day moving average is the resistance level today.

For GlaxoSmithKline stocks, the 200-day moving average is the resistance level today.

Are you interested in GlaxoSmithKline plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GlaxoSmithKline stock price in 2024, 2025, 2026, 2027, 2028. How much will one GlaxoSmithKline share be worth in 2024 - 2028?

When should I take profit in GlaxoSmithKline stock? When should I record a loss on GlaxoSmithKline stock? What are analysts' forecasts for GlaxoSmithKline stock? What is the future of GlaxoSmithKline stock? We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GlaxoSmithKline stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

GlaxoSmithKline stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GlaxoSmithKline shares. This happens once a day.


Historical and forecast chart of GlaxoSmithKline stock

The chart below shows the historical price of GlaxoSmithKline stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GlaxoSmithKline stock price can be found in the table below.

Long-term forecasts by years.

GlaxoSmithKline plc is engaged in the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, OTC drugs and health-related consumer products in the United Kingdom, the United States and internationally. It operates in four segments: pharmaceuticals, pharmaceutical research and development, vaccines and consumer healthcare. The company offers pharmaceutical products that include drugs in therapeutic areas such as respiratory, HIV, immunoinflammatory, cancer, antiviral, central nervous system, cardiovascular and urogenital, metabolic, antibacterial and dermatological. It also provides consumer healthcare products in the categories of health, oral health, nutrition, and skin health. The company offers its consumers medical products in the form of nasal sprays, tablets, syrups, lozenges, chewing gums and transdermal patches, drops, drops of baby syrup, liquid suspension, wipes, gels, effervescent substances, toothpastes, toothbrushes, mouth rinses, adhesives for dentures and detergents, topical creams and non-drug plasters, lip balms, chewing gums and soft chewing gums. She has cooperation agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics specializing in immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, UK.

GlaxoSmithKline daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 21 39.11 39.01 39.30 0.74
Jul 22 38.94 38.74 39.07 0.85
Jul 23 38.55 38.45 38.77 0.83
Jul 24 38.23 38.05 38.44 1.00
Jul 25 38.20 38.12 38.44 0.84
Jul 26 38.02 37.83 38.21 0.98
Jul 27 38.13 37.82 38.39 1.50
Jul 28 38.24 38.05 38.33 0.72
Jul 29 38.47 38.21 38.56 0.92
Jul 30 38.27 38.02 38.52 1.32
Jul 31 37.94 37.68 38.07 1.03
Aug 01 37.90 37.62 38.16 1.42
Aug 02 37.98 37.91 38.23 0.86
Aug 03 38.27 37.97 38.38 1.07
Aug 04 38.64 38.44 38.76 0.83
Aug 05 38.56 38.30 38.81 1.35
Aug 06 38.52 38.34 38.77 1.12
Aug 07 38.41 38.22 38.50 0.74
Aug 08 38.34 38.20 38.62 1.09
Aug 09 38.36 38.21 38.58 0.98
Aug 10 38.51 38.33 38.65 0.84
Aug 11 38.51 38.32 38.59 0.70
Aug 12 38.61 38.45 38.85 1.05
Aug 13 38.48 38.29 38.65 0.95
Aug 14 38.71 38.45 38.87 1.10
Aug 15 38.57 38.44 38.84 1.04
Aug 16 38.75 38.52 38.82 0.79
Aug 17 38.91 38.61 39.07 1.21
Aug 18 38.81 38.56 38.90 0.90
Aug 19 38.62 38.45 38.86 1.07

GlaxoSmithKline Daily Price Targets


GlaxoSmithKline Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $39.11.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.736%.
Pessimistic target level: 39.01
Optimistic target level: 39.30

GlaxoSmithKline Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $38.94.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.847%.
Pessimistic target level: 38.74
Optimistic target level: 39.07

GlaxoSmithKline Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $38.55.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.825%.
Pessimistic target level: 38.45
Optimistic target level: 38.77

GlaxoSmithKline Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $38.23.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.995%.
Pessimistic target level: 38.05
Optimistic target level: 38.44

GlaxoSmithKline Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $38.20.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.835%.
Pessimistic target level: 38.12
Optimistic target level: 38.44

GlaxoSmithKline Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $38.02.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.975%.
Pessimistic target level: 37.83
Optimistic target level: 38.21

GSK (GSK) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 38.55 38.24 38.92 1.75
Sep. 39.39 38.92 39.93 2.52
Oct. 38.99 38.62 39.57 2.39
Nov. 39.09 38.21 39.45 3.15
Dec. 38.89 38.13 39.70 3.97

GlaxoSmithKline forecast for this year


GlaxoSmithKline Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $38.5499. Pessimistic: $38.24. Optimistic: $38.92


GlaxoSmithKline Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $39.3941. Pessimistic: $38.92. Optimistic: $39.93


GlaxoSmithKline Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $38.9923. Pessimistic: $38.62. Optimistic: $39.57


GlaxoSmithKline Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $39.0859. Pessimistic: $38.21. Optimistic: $39.45


GlaxoSmithKline Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $38.8866. Pessimistic: $38.13. Optimistic: $39.70



GlaxoSmithKline (GSK) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 39.24 38.95 39.92 2.42
Feb 40.41 39.49 41.17 4.06
Mar 40.00 39.58 40.24 1.64
Apr 40.51 40.25 41.36 2.67
May 40.83 40.10 41.30 2.91
Jun 40.54 40.03 41.20 2.83
Jul 40.10 39.21 40.61 3.44
Aug 40.04 39.56 40.70 2.80
Sep 41.21 40.40 41.59 2.85
Oct 42.07 41.57 42.99 3.32
Nov 42.83 42.05 43.37 3.05
Dec 43.70 43.27 44.32 2.37

GlaxoSmithKline (GSK) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 43.61 42.98 44.08 2.49
Feb 44.84 43.99 45.54 3.40
Mar 44.17 43.23 44.70 3.29
Apr 42.90 41.89 43.27 3.18
May 42.34 41.86 43.27 3.26
Jun 42.24 41.30 43.14 4.26
Jul 43.48 42.81 44.49 3.78
Aug 43.03 42.41 43.67 2.90
Sep 42.43 42.04 43.43 3.20
Oct 43.10 42.13 43.88 4.01
Nov 42.18 41.75 42.57 1.93
Dec 41.32 40.76 41.73 2.32

GlaxoSmithKline (GSK) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 41.19 40.87 41.54 1.61
Feb 40.25 39.90 41.22 3.19
Mar 41.04 40.76 41.72 2.30
Apr 40.48 39.95 41.08 2.75
May 40.42 39.51 40.88 3.35
Jun 40.41 40.05 41.16 2.71
Jul 41.09 40.34 41.85 3.62
Aug 41.89 41.19 42.58 3.28
Sep 42.55 41.70 42.86 2.71
Oct 42.52 41.63 42.85 2.86
Nov 42.46 41.76 42.72 2.27
Dec 41.53 40.97 42.12 2.75

GlaxoSmithKline (GSK) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 41.63 41.16 42.21 2.49
Feb 41.79 41.06 42.34 3.02
Mar 41.40 40.41 42.33 4.55
Apr 42.13 41.63 43.09 3.40
May 41.63 40.75 42.60 4.34
Jun 42.23 41.53 42.68 2.70
Jul 42.35 41.39 43.31 4.43
Aug 43.34 42.98 43.96 2.22
Sep 44.61 44.26 45.53 2.79
Oct 45.90 45.01 46.41 3.03
Nov 45.13 44.13 45.88 3.81
Dec 44.59 43.81 45.35 3.39

GlaxoSmithKline information and performance

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization: 79 319 826 000 $

Market capitalization of the GlaxoSmithKline plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GSK shares in the company outstanding by the market price of one share.

EBITDA: 10 537 000 000 $

EBITDA of GlaxoSmithKline is earnings before interest, income tax and depreciation of assets.

PE Ratio: 13.79

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.087

Price/earnings to growth

DPS: 0.59

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0383

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.304
Quarterly Revenue Growth YOY: 0.059
Trailing PE: 13.79

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 10.32

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.319

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.08

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2039070000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

GlaxoSmithKline (GSK) stock dividend

GlaxoSmithKline last paid dividends on 05/16/2024. The next scheduled payment will be on 07/11/2024. The amount of dividends is $0.59 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.